Reunion Neuroscience Revenue and Competitors
Estimated Revenue & Valuation
- Reunion Neuroscience's estimated annual revenue is currently $5.3M per year.
- Reunion Neuroscience's estimated revenue per employee is $188,214
- Reunion Neuroscience's total funding is $103M.
Employee Data
- Reunion Neuroscience has 28 Employees.
- Reunion Neuroscience grew their employee count by 33% last year.
Reunion Neuroscience's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | SVP, Clinical Development & Regulatory Affairs | Reveal Email/Phone |
7 | Director Pharmacology & Toxicology | Reveal Email/Phone |
8 | Medical Director | Reveal Email/Phone |
9 | Sr Director CMC | Reveal Email/Phone |
10 | Senior Director Finance and Head Program Management | Reveal Email/Phone |
Reunion Neuroscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is Reunion Neuroscience?
Reunion Neuroscience is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. NASDAQ:REUN
keywords:N/A$103M
Total Funding
28
Number of Employees
$5.3M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 28 | -26% | N/A |
#2 | $3.5M | 28 | -22% | N/A |
#3 | $4.3M | 28 | -12% | $10M |
#4 | $3.3M | 28 | -26% | N/A |
#5 | $3.2M | 28 | -3% | N/A |